Aurobindo Pharma informs about company updates

17 May 2019 Evaluate

Aurobindo Pharma has informed that the Company has received letters from the USFDA classifying the inspections concluded at its API facilities of Unit I and XI and intermediates facility of unit IX in February 2019 as Official Action Indicated (OAI). The Company has already submitted its initial response to USFDA. The Company is sending further updates on the committed corrective actions. The Company is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1198.50 -8.30 (-0.69%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×